GO:0036302 atrioventricular canal development: Patterning, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036302 atrioventricular canal development describes the progression of the atrioventricular canal (AVC) from its formation to its mature structure, the part of the heart connecting the atrium to the cardiac ventricle.
• The AVC is a specialized myocardial region that acts as a signaling center and is essential for proper heart looping, chamber specification, and valve formation [2,5].
• Key transcription factors such as GATA4, HAND2, TBX2, TBX3, and NKX2-5 establish AVC identity by repressing chamber-specific genes and activating valve-forming programs [5,6,8].
• Disruption of AVC development leads to congenital heart defects, including atrioventricular septal defects (AVSD) and valve anomalies, which are among the most common human birth defects [3,7].
• Human multi-chamber cardioid models now allow researchers to study AVC development and cardiac defects in vitro, bridging the gap between animal models and human disease.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of AVC-associated genes in heart development and disease [1,5,8].
Description
The atrioventricular canal (AVC) is a critical region of the developing heart that connects the atrium to the cardiac ventricle and serves as a signaling hub for chamber specification, valve formation, and septation [2,5]. The Gene Ontology term GO:0036302, atrioventricular canal development, captures the biological processes that drive the formation and maturation of this structure. Understanding AVC development is essential because defects in this process are a major cause of congenital heart malformations, including atrioventricular septal defects and valve abnormalities [3,7]. Research over the past two decades has identified conserved transcriptional networks, including GATA and HAND2-dependent regulatory switches, that pattern the AVC and control its morphogenesis [5,8]. More recently, human multi-chamber cardioid models have provided a platform to study AVC development and cardiac defects in a human-relevant context. This article synthesizes current knowledge on the molecular and cellular mechanisms of AVC development, the genes involved, and the experimental approaches used to study this process.
atrioventricular canal development At A Glance
| GO ID | GO:0036302 |
|---|---|
| GO term | atrioventricular canal development |
| Ontology | biological_process |
| Synonym | None |
| Major function | Formation and maturation of the atrioventricular canal, including chamber boundary establishment, endocardial cushion formation, and valve development |
| Related processes | Heart looping, chamber specification, epithelial-to-mesenchymal transition, valve morphogenesis |
| Key regulators | GATA4, HAND2, TBX2, TBX3, NKX2-5, BMP2, NOTCH1 |
| Disease relevance | Atrioventricular septal defects, valve anomalies, congenital heart disease |
What Is GO:0036302?
GO:0036302 atrioventricular canal development is defined as the progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart that connects the atrium to the cardiac ventricle. This process encompasses the specification of AVC myocardium, the establishment of a boundary between the atrium and ventricle, the formation of endocardial cushions, and the remodeling events that lead to mature valve and septal structures [2,5,7].
Why Is atrioventricular canal development Important in Cell Biology?
AVC development is a cornerstone of heart morphogenesis, as it ensures proper separation of atrial and ventricular chambers and the formation of functional valves. Disruption of this process leads to congenital heart defects that require surgical intervention and can cause lifelong morbidity [3,7]. Studying AVC development provides insights into fundamental mechanisms of tissue patterning, cell fate specification, and epithelial-to-mesenchymal transition, and it informs regenerative strategies for heart repair [1,5,8].
• AVC development is essential for separating the atrial and ventricular chambers and for forming the atrioventricular valves [2,7].
• Defects in AVC development cause atrioventricular septal defects, a common form of congenital heart disease.
• The AVC acts as a signaling center that patterns the adjacent chambers and coordinates heart looping [2,5].
• GATA and HAND2-dependent transcriptional networks are critical for establishing AVC identity and valve formation [5,8].
• Human cardioid models enable the study of AVC development and cardiac defects in vitro.
• Understanding AVC development aids in identifying genetic causes of congenital heart disease.
• AVC development involves conserved mechanisms across vertebrates, making zebrafish and mouse models valuable [2,8].
• Research on AVC development informs tissue engineering and regenerative approaches for valve replacement.
What Happens During atrioventricular canal development?
Specification of the AVC myocardium
In simple terms: The heart tube first forms a specialized region called the atrioventricular canal, which will later become the connection between the upper and lower heart chambers.
During early heart development, the linear heart tube is patterned along its anterior-posterior axis into distinct regions: the atrium, atrioventricular canal (AVC), and ventricle. The AVC is specified by a combination of transcription factors, including TBX2, TBX3, and GATA4, which repress chamber-specific genes such as NPPA and activate AVC-specific genes [5,6]. In zebrafish, the AVC is marked by the expression of bmp4 and versican, and its formation requires proper heart looping. The specification of the AVC is a prerequisite for subsequent valve formation and septation.
Formation of the endocardial cushions
In simple terms: Cells from the inner lining of the heart move into the space between the heart layers to form cushions that will become the heart valves.
Once the AVC is specified, the endocardium undergoes an epithelial-to-mesenchymal transition (EMT), producing mesenchymal cells that populate the extracellular matrix between the endocardium and myocardium, forming the endocardial cushions. This process is regulated by signaling molecules such as BMP2 and TGF-beta, which are secreted by the AVC myocardium [2,8]. The endocardial cushions serve as precursors for the atrioventricular valves and the membranous part of the interventricular septum.
Remodeling and valve formation
In simple terms: The cushions are reshaped into thin, strong valves that open and close to control blood flow.
After the endocardial cushions form, they undergo remodeling through apoptosis, proliferation, and extracellular matrix reorganization to form the mature atrioventricular valves (mitral and tricuspid valves). This process involves complex signaling interactions between the myocardium, endocardium, and neural crest-derived cells. Defects in remodeling lead to valve stenosis or regurgitation, as seen in congenital heart disease.
Transcriptional regulation of AVC identity
In simple terms: A set of master control proteins switch on the genes that make the AVC different from the rest of the heart.
The AVC identity is maintained by a network of transcription factors. GATA4 and GATA6, together with HAND2, establish AVC-specific regulatory switches that repress chamber-specific genes and activate valve-forming genes [5,8]. TBX2 and TBX3 are also expressed in the AVC and function to repress chamber-specific genes, thereby maintaining the AVC boundary. Disruption of these factors leads to loss of AVC identity and congenital heart defects.
Signaling pathways in AVC development
In simple terms: Chemical signals tell the cells in the AVC what to do and when to do it.
Multiple signaling pathways, including BMP, TGF-beta, NOTCH, and WNT, are involved in AVC development. BMP2 and BMP4, secreted by the AVC myocardium, induce EMT in the endocardium. NOTCH1 signaling in the endocardium is required for EMT and valve formation. WNT/beta-catenin signaling also plays a role in cushion formation and remodeling. These pathways are highly conserved across vertebrates and are essential for proper AVC development.
Key Genes Involved in GO:0036302 atrioventricular canal development
The following genes are key regulators of atrioventricular canal development, as identified in model organisms and human studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GATA4 | Transcription factor that establishes AVC identity and regulates valve formation | Mutations cause congenital heart defects; key for AVC-specific regulatory switches [5,6] |
| HAND2 | Transcription factor that controls AVC and valve development | Target gene networks are essential for AVC morphogenesis |
| TBX2 | Represses chamber-specific genes in the AVC | Maintains AVC boundary; knockout leads to chamber expansion |
| TBX3 | Represses chamber-specific genes in the AVC | Cooperates with TBX2 to pattern the AVC |
| NKX2-5 | Homeobox transcription factor involved in heart development | Mutations associated with AVSD and other congenital heart defects |
| BMP2 | Signaling molecule that induces EMT in the AVC | Critical for endocardial cushion formation |
| BMP4 | Signaling molecule expressed in the AVC | Marks the AVC in zebrafish; regulates cushion formation |
| NOTCH1 | Signaling receptor required for EMT and valve formation | Mutations linked to bicuspid aortic valve and other valve defects |
| TGF-beta | Signaling molecule that regulates EMT and cushion remodeling | Involved in valve development and disease |
| VERSICAN | Extracellular matrix proteoglycan expressed in the AVC | Marks the AVC in zebrafish; involved in cushion formation |
| NPPA | Chamber-specific gene repressed in the AVC | Used as a marker to assess AVC identity |
| MEF2C | Transcription factor involved in heart development | Cooperates with GATA and HAND2 in AVC gene regulation |
| SOX9 | Transcription factor involved in valve development | Regulates EMT and cushion formation |
| PITX2 | Transcription factor involved in left-right asymmetry and heart development | Mutations associated with atrial septal defects |
| SMAD4 | Mediator of TGF-beta/BMP signaling | Required for endocardial cushion formation |
| VEGFA | Angiogenic factor involved in valve development | Regulates endocardial cell behavior |
| WNT9B | Signaling molecule involved in AVC development | Regulates cushion formation and remodeling |
| HAS2 | Hyaluronan synthase involved in cushion matrix expansion | Essential for endocardial cushion formation |
How Is atrioventricular canal development Regulated?
AVC development is regulated by a complex interplay of transcription factors and signaling pathways. GATA4 and HAND2 establish AVC-specific regulatory switches that repress chamber-specific genes and activate valve-forming programs [5,8]. TBX2 and TBX3 reinforce the AVC boundary by repressing chamber-specific genes. Signaling pathways such as BMP, TGF-beta, NOTCH, and WNT modulate EMT and cushion remodeling [2,7]. Epigenetic regulators and microRNAs also contribute to the precise spatiotemporal control of AVC development.
atrioventricular canal development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATA4 | Atrioventricular septal defects, congenital heart disease | Knockout mouse, human cardioid model [1,5] |
| HAND2 | AVSD, valve defects | Knockout mouse, zebrafish |
| NKX2-5 | AVSD, tetralogy of Fallot | Knock-in mouse, patient-derived iPSCs |
| NOTCH1 | Bicuspid aortic valve, valve calcification | Knockout mouse, zebrafish |
| TBX2 | AVC boundary defects, chamber expansion | Knockout mouse, overexpression models |
Atrioventricular septal defects (AVSD)
AVSD is a congenital heart defect characterized by a common atrioventricular valve and a defect in the atrial and/or ventricular septum. It results from failure of AVC development, including incomplete fusion of the endocardial cushions. Mutations in genes such as GATA4, NKX2-5, and HAND2 have been associated with AVSD in humans and animal models [5,6,8].
Valve anomalies
Defects in AVC remodeling can lead to valve stenosis or regurgitation, such as bicuspid aortic valve and mitral valve prolapse. NOTCH1 mutations are linked to valve anomalies, and disrupted TGF-beta signaling contributes to valve disease.
Syndromic heart defects
AVC development defects are features of several syndromes, including McKusick-Kaufman syndrome, which is characterized by congenital heart defects among other anomalies. Understanding the genetic basis of these syndromes provides insights into AVC development.
From atrioventricular canal development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of GATA4 in AVC specification? | Knockout and point-mutation models in mouse and human cardioids [1,5] |
| How does HAND2 regulate valve formation? | Knockout and overexpression in zebrafish and mouse |
| What are the downstream targets of TBX2 in the AVC? | Knock-in tagged TBX2 for ChIP-seq, knockout models |
| How do NOTCH1 mutations lead to valve disease? | Point-mutation knock-in in mouse and human iPSCs |
| What is the function of BMP2 in endocardial cushion formation? | Conditional knockout in mouse endocardium |
| Can human cardioids model AVC development? | Multi-chamber cardioid differentiation from hiPSCs |
How to Study the atrioventricular canal development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify AVC-specific transcripts and pathways |
| ChIP-seq | Transcription factor binding sites | Map GATA4 and HAND2 targets in AVC [5,8] |
| Single-cell RNA-seq | Cell-type-specific expression | Resolve AVC cell heterogeneity |
| Light-sheet microscopy | 3D morphology and dynamics | Visualize AVC development in zebrafish |
| Lineage tracing | Cell fate and contribution | Trace endocardial and neural crest cells in valves |
| Proteomics | Protein abundance and modifications | Identify signaling changes in AVC |
| CRISPR screening | Gene function at scale | Discover novel AVC regulators |
| Human cardioid differentiation | Human heart development in vitro | Model AVC development and disease |
Transcriptomics and epigenomics
RNA-seq and ChIP-seq are used to identify AVC-specific gene expression programs and transcription factor binding sites. These methods have revealed GATA and HAND2 target networks in the AVC [5,8]. Single-cell RNA-seq can resolve cellular heterogeneity within the AVC and identify novel regulators.
Imaging and lineage tracing
Confocal and light-sheet microscopy combined with fluorescent reporters allow visualization of AVC development in real time. Lineage tracing using Cre-lox systems in mice has elucidated the contribution of endocardial and neural crest cells to valve formation.
Human cardioid models
Multi-chamber cardioids derived from human induced pluripotent stem cells (hiPSCs) recapitulate key aspects of AVC development and can be used to study cardiac defects in vitro. These models enable CRISPR-based gene editing to test the function of candidate genes.
Proteomics and signaling assays
Mass spectrometry-based proteomics and phosphoproteomics can identify signaling changes in AVC development. Western blotting and immunofluorescence are used to validate pathway activation, such as BMP and TGF-beta signaling [2,7].
How CRISPR Can Be Used to Study GO:0036302 atrioventricular canal development
Knockout
CRISPR knockout of AVC-associated genes such as GATA4, HAND2, and TBX2 in cell models and animal models can reveal their essential roles in AVC development. For example, knockout of GATA4 in human cardioids disrupts AVC specification and valve formation [1,5].
Point Mutation
Point mutations identified in patients with congenital heart defects can be introduced into cell models using CRISPR base editing or homology-directed repair. These models help determine whether a specific variant is pathogenic and how it affects AVC development.
Knock-in
Knock-in of fluorescent tags or reporter genes (e.g., GFP, luciferase) into AVC-specific loci allows real-time monitoring of gene expression and cell behavior during AVC development. Tagged knock-in of transcription factors enables ChIP-seq and proteomic studies [5,8].
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to study the effects of increased gene dosage of AVC regulators. Overexpression of TBX2 or HAND2 in zebrafish or mouse models can lead to valve defects and altered chamber specification [6,8].
How EDITGENE Supports atrioventricular canal development Research
Researchers studying atrioventricular canal development-related genes often need to determine whether a candidate gene is causally involved in AVC formation, valve development, or congenital heart defects. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout and point-mutation models to knock-in reporters and overexpression systems, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for atrioventricular canal development research.
Frequently Asked Questions About atrioventricular canal development
What is atrioventricular canal development?
Atrioventricular canal development (GO:0036302) is the biological process by which the atrioventricular canal, the part of the heart connecting the atrium to the ventricle, forms and matures, including chamber boundary establishment, endocardial cushion formation, and valve development [2,5,7].
What genes are involved in atrioventricular canal development?
Key genes include GATA4, HAND2, TBX2, TBX3, NKX2-5, BMP2, BMP4, NOTCH1, and TGF-beta, which regulate AVC specification, EMT, and valve formation [5,6,8].
What diseases are associated with atrioventricular canal development defects?
Defects in AVC development cause atrioventricular septal defects (AVSD), valve anomalies, and syndromic heart defects such as McKusick-Kaufman syndrome [3,4,7].
How is atrioventricular canal development studied?
Researchers use animal models (zebrafish, mouse), human cardioid models, RNA-seq, ChIP-seq, imaging, and CRISPR-based gene editing to study AVC development [1,2,5].
What is the role of GATA4 in atrioventricular canal development?
GATA4 is a transcription factor that establishes AVC identity by repressing chamber-specific genes and activating valve-forming programs; mutations are linked to AVSD [5,6].
What is the function of HAND2 in AVC development?
HAND2 controls AVC and valve development through target gene regulatory networks; its disruption leads to valve defects.
How do endocardial cushions form?
Endocardial cushions form when endocardial cells undergo epithelial-to-mesenchymal transition (EMT) in response to BMP and TGF-beta signals from the AVC myocardium [2,7].
What signaling pathways regulate AVC development?
BMP, TGF-beta, NOTCH, and WNT signaling pathways regulate AVC specification, EMT, and cushion remodeling [2,7].
Can human cardioids model AVC development?
Yes, multi-chamber cardioids derived from hiPSCs recapitulate key aspects of human AVC development and can be used to study cardiac defects.
How can CRISPR help study AVC development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of AVC-associated genes in human cells and animal models [1,5,8].
Conclusion
Atrioventricular canal development (GO:0036302) is a fundamental process in heart morphogenesis that ensures proper chamber separation and valve formation. Disruption of this process leads to congenital heart defects, making it a critical area of research. Advances in human cardioid models and CRISPR-based gene editing are accelerating the discovery of AVC regulatory networks and disease mechanisms [1,5,8]. EDITGENE provides comprehensive services to support this research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Schmidt C et al.. 2023. Multi-chamber cardioids unravel human heart development and cardiac defects.. Cell 186(25):5587-5605.e27 PMID: 38029745
- 2. Peal DS et al.. 2011. Patterning and development of the atrioventricular canal in zebrafish.. J Cardiovasc Transl Res 4(6):720-6 PMID: 21948390
- 3. Murphy DJ Jr. 1999. Atrioventricular Canal Defects.. Curr Treat Options Cardiovasc Med 1(4):323-334 PMID: 11096498
- 4. Adam MP et al.. 1993. McKusick-Kaufman Syndrome.. PMID: 20301675
- 5. Stefanovic S et al.. 2014. GATA-dependent regulatory switches establish atrioventricular canal specificity during heart development.. Nat Commun 5:3680 PMID: 24770533
- 6. Grunert M et al.. 2024. Cardiac Transcription Factors and Regulatory Networks.. Adv Exp Med Biol 1441:295-311 PMID: 38884718
- 7. Kim JS et al.. 2001. Development of the myocardium of the atrioventricular canal and the vestibular spine in the human heart.. Circ Res 88(4):395-402 PMID: 11230106
- 8. Laurent F et al.. 2017. HAND2 Target Gene Regulatory Networks Control Atrioventricular Canal and Cardiac Valve Development.. Cell Rep 19(8):1602-1613 PMID: 28538179
